ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IFRX InflaRx NV

1.35
-0.03 (-2.17%)
After Hours
Last Updated: 17:00:02
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
InflaRx NV IFRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.03 -2.17% 1.35 17:00:02
Open Price Low Price High Price Close Price Previous Close
1.40 1.28 1.4492 1.36 1.38
more quote information »

Recent News

Date Time Source Heading
4/30/202406:30GLOBEInflaRx to Host Virtual R&D Event on June 5, 2024 and..
4/24/202406:30GLOBEInflaRx to Participate in Capital One Securities 1st Annual..
3/21/202406:00GLOBEInflaRx Reports Full Year 2023 Results and Announces INF904..
3/19/202406:30GLOBEInflaRx to Announce Development Plans for INF904 and 2023..
2/22/202406:30GLOBEInflaRx Appoints Jan Medina as Head of Investor Relations
1/25/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/25/202406:30GLOBEInflaRx Announces Initiation of its Commitment Program for..
1/04/202415:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/04/202406:00GLOBEInflaRx Announces Positive Topline Results from the Multiple..
11/06/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/06/202306:30GLOBEInflaRx Announces First Patient Dosed in Phase III Trial..
11/01/202307:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/01/202306:30GLOBEInflaRx Reports Third Quarter 2023 Financial Results and..
9/11/202307:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/11/202306:00GLOBEInflaRx Announces Positive Topline Results from the Single..
8/30/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/30/202306:30GLOBEInflaRx’s Marketing Authorization Application (MAA) for..
8/10/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/10/202306:30GLOBEInflaRx Reports Second Quarter 2023 Financial Results &..
7/12/202315:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
7/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
6/30/202315:06EDGAR2Form F-3 - Registration statement by foreign private issuers
6/28/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/28/202306:30GLOBEInflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
6/21/202306:00GLOBEInflaRx Announces Commercial Launch of Gohibic (vilobelimab)..
5/11/202306:30GLOBEInflaRx Reports First Quarter 2023 Financial and Operating..

Your Recent History

Delayed Upgrade Clock